1. Abelmann WH. Myocarditis as a cause of dilated cardiomyopathy. In: Engelmeier BS, O’Connel JB (eds.) (1988) Drug therapy in dilated cardiomyopathy and myocarditis. New York: Marcel Dekker, pp 221–31
2. Ansari A A, Wang Y-C, Danner DJ et al. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol; 139:337–54
3. Ansari AA, Neckelmann N, Wang Y-C, Gravenis MC, Sell KW, Herskowitz A (1993) Immunologic dialogue between cardiac myocytes, endothelial cells and mononuclear cells. Clin Immunol Immunopathol 68:208–14
4. Borda ES, Pascual J, Cossio PM, Vega M, Arana RM, Sterin-Borda L (1984) Circulating IgG in Chagas disease which binds to β-adrenoceptor of myocardium and modulates ist activity. Clin Exp Immunol 57:679–86
5. Bristrow MR (1993) Pathophysiology and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. Am J Cardiol 71:12C-22C